Mohammadreza Babaei: Anticoagulation versus No Anticoagulation after Intracranial Hemorrhage in Patients with Atrial Fibrillation
Amir Ghaffari Jolfayi, Research Assistant at Rajaie Cardiovascular, Medical and Research Institute, quoted Mohammadreza Babaei’s post on LinkedIn:
“Excited to share our latest publication in BMC Cardiovascular Disorders!
Title: Anticoagulation versus no anticoagulation after intracranial hemorrhage in patients with atrial fibrillation: an updated systematic review and meta-analysis
Key findings: This meta-analysis of five randomized controlled trials shows that anticoagulation reduces thromboembolic events in patients with atrial fibrillation after intracranial hemorrhage, but is associated with a notably higher risk of recurrent bleeding. It underscores the need for personalized, patient-specific decision-making to balance these risks and benefits.
Special Thanks to Mohammadreza Babaei and the team!
Read the full article here”
Title: Anticoagulation versus no anticoagulation after intracranial hemorrhage in patients with atrial fibrillation: an updated systematic review and meta-analysis
Authors: Mohammadreza Babaei, Parisa Fallahtafti, Sina Rashedi, Amir Ghaffari Jolfayi, Zahra Hosseini, Kaveh Hosseini, Masih Tajdini, Hamidreza Soleimani
Quoting Mohammadreza Babaei’s post:
“Check out our recently published article in BMC Cardiovascular Disorders, titled:
“Anticoagulation versus no anticoagulation after intracranial hemorrhage in patients with atrial fibrillation: an updated systematic review and meta-analysis”
The results of this meta-analysis of five RCTs suggest that anticoagulation provides clinically meaningful reductions in thromboembolic events, but at the cost of a significantly increased risk of bleeding in this population. These findings indicate the importance of carefully selecting patients on an individual basis when weighing the benefits and risks of therapy.
Many thanks to the team members, Parisa Fallahtafti, Sina Rashedi, and Amir Ghaffari Jolfayi for their dedication, and our professors Hamidreza Soleimani, Zahra Hosseini, Kaveh Hosseini, Masih Tajdini for their support and guidance.”
Discover the latest in Hemostasis Today.
-
Feb 25, 2026, 16:47Alan Nurden: Platelet Defects Explain Bleeding in EHDS Patients
-
Feb 25, 2026, 16:40Mohammed Almohammadi: Uniting Leaders in Laboratory Hematology at the 1st Saudi ISLH Joint Conference
-
Feb 25, 2026, 16:37Salihu Asimawu: Inflammation Is Not a Disease – Hats Off to the Heroes Inside Us
-
Feb 25, 2026, 16:34Michael Makris: Biomarin Has Decided to Withdraw Roctavian from the Market
-
Feb 25, 2026, 16:25Tagreed Alkaltham: The Blood Banker Personality
-
Feb 25, 2026, 16:17Sanjay Ahuja: Insightful Talk on 100 Years of VWD by Jorge Di Paola
-
Feb 25, 2026, 15:20Michael Shapiro։ Creating Real Pathways for Trainees in Preventive Cardiology
-
Feb 25, 2026, 15:15Ajay Kumar: Plasma Component Quality Control Standards
-
Feb 25, 2026, 15:09Wolfgang Miesbach: Efficacy, Safety and Thrombosis Signals in Haemophilia A/B with Inhibitors